Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniel Albert Geller, M.B.,B.S.

Co-Author

This page shows the publications co-authored by Daniel Geller and Thomas Spencer.
Connection Strength

0.630
  1. Attention-deficit/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: fact or artifact? J Am Acad Child Adolesc Psychiatry. 2002 Jan; 41(1):52-8.
    View in: PubMed
    Score: 0.252
  2. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. J Atten Disord. 2008 Jan; 11(4):470-81.
    View in: PubMed
    Score: 0.094
  3. Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment. J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):689-700.
    View in: PubMed
    Score: 0.094
  4. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry. 2003 Nov; 160(11):1919-28.
    View in: PubMed
    Score: 0.072
  5. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2002 Jul; 59(7):649-56.
    View in: PubMed
    Score: 0.065
  6. Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate. J Pediatr. 2013 Jan; 162(1):22-7.e2.
    View in: PubMed
    Score: 0.033
  7. Donepezil in the treatment of ADHD-like symptoms in youths with pervasive developmental disorder: a case series. J Atten Disord. 2006 Feb; 9(3):543-9.
    View in: PubMed
    Score: 0.021
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.